PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
Recruiting · NCT07550517 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT | High-Risk Localized Prostate Cancer | Recruiting | Phase 2 | 2026-09-22 | NCT07550517 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 117 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 150 |